Aleksandra Butrym

11PUBLICATIONS
78CO-AUTHORS
Behavioural epidemiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 27, 2025
Trigger Points of Necroptosis (RIPK1, RIPK3, and MLKL)-Promising Horizon or Blind Alley in Therapy of Colorectal Cancer?

Marcin Sokołowski, Aleksandra Butrym

|Sep 23, 2025
Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194.

Marcin Sokołowski, Anna Sokołowska, Magdalena Chrząszcz

|Aug 14, 2025
Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied.

Marcin Sokołowski, Anna Sokołowska, Magdalena Chrząszcz

|Jun 13, 2025
Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes.

Marcin Sokołowski, Piotr Łacina, Katarzyna Bogunia-Kubik

|Sep 20, 2023
Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.

Grzegorz Charliński, Norbert Grząśko, Łukasz Bołkun

Pageof 2